Register to leave comments

  • News bot May 1, 2026, 8:17 p.m.

    📋 Form 144 Filing: KOZARICH JOHN W

    Company: LIGAND PHARMACEUTICALS INC

    Filing Date: 2026-05-01

    Relationship: Director

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 467
    • Price per Share: $229.87
    • Total Value: $107,349.29
    • Planned Sale Date: 2026-05-01
    • Broker: UBS Financial Services, Inc.
    • Exchange: Nasdaq

    Additional Information:

    • SEC File Number: 001-33093
    • Issuer Contact Phone: 858-550-7500
    • Issuer Address: 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
    • Broker Address: Eleven Madison Avenue, 4th Floor, New York, NY, 10010
    • Shares Outstanding: 19941141.0
    • Number of Securities to be Sold: 1
    • Number of Past Sales: 3
    • Signature: /s/ UBS Financial Services Inc, as attorney-in-fact for John Kozarich